Skip to content

Vir Biotechnology, Inc. VIR Professional service fees

Professional service fees at other companies

Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
Nuvation Bio logo
Nuvation BioNUVB
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
Krystal Biotech, Inc. logo
Krystal Biotech, Inc.KRYS

Other financials

Income statement

See full
Revenue-$29.0K-101%
Gross profit$1.2M-60.2%
Operating income-$132.3M+5.2%
Net income-$125.7M-3.9%
EPS (diluted)-$0.85+3.4%

Balance sheet

See full
Cash & equivalents$283.0M-23.1%
Total debt$95.6M-0.5%
Total equity$812.8M-22.1%
Total assets$1.0B-21.6%

Cash flow

See full
Operating cash flow-$132.4M-69.5%
CapEx$390.0K-76.1%
Free cash flow-$132.8M-66.5%

Valuation

See full
Market cap$1.68B+61.1%

Profitability

See full
Gross margin96.1%-2.7pp
Operating margin-720.8%-313pp
Net margin-676%-291pp
FCF margin-686.5%-273pp

Returns & leverage

See full
Return on equity-47.7%+3.6pp
Debt / equity0.1×0.0×
Current ratio7.1×+0.3×

Where this comes from

Reported directly by Vir Biotechnology, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AccruedProfessionalFeesCurrent.

The official record: Vir Biotechnology, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vir Biotechnology, Inc.'s professional service fees.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vir Biotechnology, Inc.'s professional service fees?
Vir Biotechnology, Inc. (VIR) reported professional service fees of $3.39M in Q1 2026.
How has Vir Biotechnology, Inc.'s professional service fees changed year-over-year?
Vir Biotechnology, Inc.'s professional service fees increased by 63.8% year-over-year, from $2.07M to $3.39M.
What is the long-term trend for Vir Biotechnology, Inc.'s professional service fees?
Over 3 years (2022 to 2025), Vir Biotechnology, Inc.'s professional service fees has grown at a -5.9% compound annual growth rate (CAGR), from $3.99M to $3.33M.